These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35379296)

  • 1. Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate to severe ARDS in a randomized, placebo-controlled, double-blind trial: preliminary evaluation of safety and feasibility in light of the COVID-19 pandemic.
    Schmid B; Kranke P; Lucas R; Meybohm P; Zwissler B; Frank S
    Trials; 2022 Apr; 23(1):252. PubMed ID: 35379296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS-a randomized, placebo-controlled, double-blind trial.
    Schmid B; Kredel M; Ullrich R; Krenn K; Lucas R; Markstaller K; Fischer B; Kranke P; Meybohm P; Zwißler B; Frank S;
    Trials; 2021 Sep; 22(1):643. PubMed ID: 34544463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.
    Atmowihardjo LN; Schippers JR; Duijvelaar E; Bartelink IH; Bet PM; Swart NEL; van Rein N; Purdy K; Cavalla D; McElroy A; Fritchley S; Vonk Noordegraaf A; Endeman H; van Velzen P; Koopmans M; Bogaard HJ; Heunks L; Juffermans N; Schultz MJ; Tuinman PR; Bos LDJ; Aman J
    Crit Care; 2023 Jun; 27(1):226. PubMed ID: 37291677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial.
    Krenn K; Lucas R; Croizé A; Boehme S; Klein KU; Hermann R; Markstaller K; Ullrich R
    Crit Care; 2017 Jul; 21(1):194. PubMed ID: 28750677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial.
    Monsel A; Hauw-Berlemont C; Mebarki M; Heming N; Mayaux J; Nguekap Tchoumba O; Diehl JL; Demoule A; Annane D; Marois C; Demeret S; Weiss E; Voiriot G; Fartoukh M; Constantin JM; Mégarbane B; Plantefève G; Malard-Castagnet S; Burrel S; Rosenzwajg M; Tchitchek N; Boucher-Pillet H; Churlaud G; Cras A; Maheux C; Pezzana C; Diallo MH; Ropers J; Menasché P; Larghero J;
    Crit Care; 2022 Feb; 26(1):48. PubMed ID: 35189925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial.
    Richard JC; Yonis H; Bitker L; Roche S; Wallet F; Dupuis C; Serrier H; Argaud L; Thiery G; Delannoy B; Pommier C; Abraham P; Muller M; Aubrun F; Sigaud F; Rigault G; Joffredo E; Mezidi M; Terzi N; Rabilloud M
    Trials; 2021 Oct; 22(1):692. PubMed ID: 34635128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS.
    Rasch S; Schmidle P; Sancak S; Herner A; Huberle C; Schulz D; Mayr U; Schneider J; Spinner CD; Geisler F; Schmid RM; Lahmer T; Huber W
    Sci Rep; 2021 Jun; 11(1):11524. PubMed ID: 34075155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/acute respiratory distress syndrome.
    Kushimoto S; Taira Y; Kitazawa Y; Okuchi K; Sakamoto T; Ishikura H; Endo T; Yamanouchi S; Tagami T; Yamaguchi J; Yoshikawa K; Sugita M; Kase Y; Kanemura T; Takahashi H; Kuroki Y; Izumino H; Rinka H; Seo R; Takatori M; Kaneko T; Nakamura T; Irahara T; Saito N; Watanabe A;
    Crit Care; 2012 Dec; 16(6):R232. PubMed ID: 23232188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.
    Sitbon A; Hauw-Berlemont C; Mebarki M; Heming N; Mayaux J; Diehl JL; Demoule A; Annane D; Marois C; Demeret S; Weiss E; Voiriot G; Fartoukh M; Constantin JM; Mégarbane B; Plantefève G; Boucher-Pillet H; Churlaud G; Cras A; Maheux C; Pezzana C; Diallo MH; Lebbah S; Ropers J; Salem JE; Straus C; Menasché P; Larghero J; Monsel A;
    Stem Cell Res Ther; 2024 Apr; 15(1):109. PubMed ID: 38637891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, Placebo-controlled Trial of Inhaled Treprostinil for Patients at Risk for Acute Respiratory Distress Syndrome.
    Ford HJ; Anderson WH; Wendlandt B; Bice T; Ceppe A; Lanier J; Carson SS
    Ann Am Thorac Soc; 2021 Apr; 18(4):641-647. PubMed ID: 33095030
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study.
    Shi R; Lai C; Teboul JL; Dres M; Moretto F; De Vita N; Pham T; Bonny V; Mayaux J; Vaschetto R; Beurton A; Monnet X
    Crit Care; 2021 Jun; 25(1):186. PubMed ID: 34074313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Dixon B; Smith RJ; Campbell DJ; Moran JL; Doig GS; Rechnitzer T; MacIsaac CM; Simpson N; van Haren FMP; Ghosh AN; Gupta S; Broadfield EJC; Crozier TME; French C; Santamaria JD;
    Lancet Respir Med; 2021 Apr; 9(4):360-372. PubMed ID: 33493448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.
    Gommans DHF; Nas J; Pinto-Sietsma SJ; Koop Y; Konst RE; Mensink F; Aarts GWA; Konijnenberg LSF; Cortenbach K; Verhaert DVM; Thannhauser J; Mol JQ; Rooijakkers MJP; Vos JL; van Rumund A; Vart P; Hassing RJ; Cornel JH; de Jager CPC; van den Heuvel MM; van der Hoeven HG; Verbon A; Pinto YM; van Royen N; van Kimmenade RRJ; ; de Leeuw PW; van Agtmael MA; Bresser P; ; van Gilst WH; Vonk-Noordergraaf A; Tijssen JGP; ; van Royen N; de Jager CPC; van den Heuvel MM; van der Hoeven HG; Verbon A; Pinto YM; van Kimmenade RRJ
    Am Heart J; 2020 Aug; 226():60-68. PubMed ID: 32512291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.
    Beloncle F; Studer A; Seegers V; Richard JC; Desprez C; Fage N; Merdji H; Pavlovsky B; Helms J; Cunat S; Mortaza S; Demiselle J; Brochard L; Mercat A; Meziani F
    Crit Care; 2021 Jul; 25(1):248. PubMed ID: 34266454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.
    Dubrovskyi O; Hasten E; Dudek SM; Flavin MT; Chan LL
    SLAS Discov; 2021 Oct; 26(9):1079-1090. PubMed ID: 34269109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial.
    Haeberle HA; Calov S; Martus P; Serna-Higuita LM; Koeppen M; Goll A; Bernard A; Zarbock A; Meersch M; Weiss R; Mehrländer M; Marx G; Putensen C; Bakchoul T; Magunia H; Nieswandt B; Mirakaj V; Rosenberger P
    Respir Res; 2023 Feb; 24(1):58. PubMed ID: 36805707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
    Fragoso-Saavedra S; Iruegas-Nunez DA; Quintero-Villegas A; García-González HB; Nuñez I; Carbajal-Morelos SL; Audelo-Cruz BM; Arias-Martínez S; Caro-Vega Y; Calva JJ; Luqueño-Martínez V; González-Duarte A; Crabtree-Ramírez B; Crispín JC; Sierra-Madero J; Belaunzarán-Zamudio PF; Valdés-Ferrer SI
    BMC Infect Dis; 2020 Oct; 20(1):765. PubMed ID: 33066761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
    Grigoropoulos I; Tsioulos G; Kastrissianakis A; Shapira S; Green O; Rapti V; Tsakona M; Konstantinos T; Savva A; Kavatha D; Boumpas D; Syrigos K; Xynogalas I; Leontis K; Ntousopoulos V; Sakka V; Sardelis Z; Fotiadis A; Vlassi L; Kontogianni C; Levounets A; Poulakou G; Gaga M; MacLoughlin R; Stebbing J; Arber N; Antoniadou A; Tsiodras S
    Respir Res; 2024 Apr; 25(1):151. PubMed ID: 38561798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.